Zealand Pharma A/s Aktie
56,58 €
Deine Einschätzung
Zealand Pharma A/s Aktie
Was spricht für und gegen Zealand Pharma A/s in den nächsten Jahren?
Pro
Kontra
Rendite von Zealand Pharma A/s im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | 4,02 % | 0,50 % | -10,36 % | -39,78 % | -11,57 % | 94,57 % | - |
| Saniona AB | 4,15 % | -0,25 % | 0,25 % | 247,86 % | 6,10 % | 684,20 % | 4,36 % |
| Actinium Pharmaceuticals Inc. | 1,58 % | -2,86 % | -9,76 % | -2,03 % | -4,23 % | -87,66 % | -83,25 % |
| NanoViricides Inc. | 0,00 % | 0,00 % | -6,37 % | -15,49 % | 2,69 % | -25,97 % | -64,63 % |
Kommentare
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big



